Completed Series C Financing

The undersigned served as Strategic and Financial Advisor to NanoHive.

has sold its assets to

The undersigned acted as exclusive strategic & financial advisor to Direct Diagnostics

has acquired the assets of

The undersigned acted as exclusive strategic & financial advisor to Athersys, Inc.
Maxim Biomedical, Inc.

has received a minority investment from

PVFO
The undersigned acted as exclusive strategic and financial advisor to Maxim Biomedical, Inc.

$175 Million

Has been acquired by

The undersigned acted as exclusive strategic advisor to Peterson Companies, majority shareholder of Propella

Has been acquired by

The undersigned acted as exclusive strategic and financial advisor to ERS

Has been acquired by

The undersigned acted as strategic and financial advisor to Innara Health
Elios

$32 Million

Has Completed a Growth Equity Financing

The undersigned acted as exclusive strategic & financial advisor to ELIOS Vision, Inc.

Has Completed an Oversubscribed Growth Equity Round

The undersigned acted as exclusive strategic & financial advisor to NanoHive Medical, LLC.

Received an equity investment from

The undersigned acted as the exclusive strategic & financial advisor to Innara Health, Inc.

Has sold its business to

The undersigned acted as the exclusive strategic & financial advisor to Verrix, LLC

Has sold its business to

The undersigned acted as exclusive Strategic & financial Advisor to Boston Healthcare Associates, Inc.

Has Acquired

$120 Million

GenePOC
The undersigned acted as exclusive strategic & financial Advisor to GenePOC

Has Sold Its Business To

The undersigned acted as exclusive strategic & financial Advisor to Beryllium

Has Sold Its Business To

Exclusive Financial Advisor to ColonaryConcepts

Has Sold Its Business To

Exclusive Financial Advisor to Advanced Uro-Solutions

Has Issued 5,000,000 Shares of Series A Preferred Stock

Exclusive Financial Advisor to Predictive Therapeutics

Has Sold Its Business To

Exclusive Financial Advisor to Coherex Medical

Completed Its Debt & Equity Financing & Distribution Agreement With

Exclusive Financial Advisor to Ember Therapeutics

Has Sold Its Business To

Exclusive Financial Advisor to nanoMR

Contact Us for More Information

Would you like to learn more about working with Outcome Capital or discuss your specific needs?

Contact Us

  • Boston

    20 Custom House St, Suite 1200, Boston, MA 02110
    (617) 431-2278